Dear participants!
Since 2022, thanks to your support, MLC has progressed from development to preparing for production of its original continuous glucose monitoring (CGM) system.
We are currently working toward CE certification. This paves the way for the next stage: sales and scaling.
We thank each and every one of you for your trust.
At the next stage, we need to secure additional funding by bringing in major investors and moving to a different legal status that ensures a transparent structure.
To move to the next stage, we will streamline the investor register and documentation.
As a result, the private funding round will be concluded. Expected completion timeframe: late 2026 — Q1 2027.
This deadline is driven by the need to prepare documents for the next stage. The company may adjust the timeframe slightly within this period, depending on their readiness.
After the round closes, new participants will no longer be registered, and new agreements, including new installment plans, will no longer be executed.
All existing agreements and installment arrangements continue in force under their original terms. No further action is required from you at this point.
Detailed information about the next stage will be provided later, as and when the documents are prepared.
Kind regards,
The MLC Team
